ZoeNCure Therapeutics

ZoeNCure Therapeutics is an India-based biotechnology and clinical development company focused on advancing innovative cancer therapies. The company leverages its specialized clinical infrastructure and development capital to execute early-phase clinical studies through strategic partnerships. Notably, ZoeNCure has partnered with Styx Biotechnologies to accelerate the development of next-generation antibody-drug conjugates (ADCs) targeting solid tumors, including liver, gastric, and rare cancers. By providing end-to-end support across preclinical, CMC, regulatory, and early clinical phases, ZoeNCure enables capital-efficient pathways for oncology drug development.